The demand for pork and poultry products is strongly influenced by the consumers concern for healthy and safe food. The topic of food safety mainly concentrates on Salmonella contamination and is recently joined by the topic of antimicrobial resistance due to the use of antimicrobial growth promoters (AGP) in animal feed. Recent research findings on Flavomycin (flavophospholipol), registered as an AGP for pigs, poultry and cattle, describe a reducing effect on the development of antibiotic resistance and on the frequency of plasmid transfer. Flavophospholipol does not induce an antibiotic resistance to antibiotics used for veterinary or human therapy as it is not related to any antibiotic used for these purposes. Furthermore, it is capable of reducing antibiotic resistance to other antibiotics. This effect seems to be yielded by interfering in the biosynthesis of the plasmid bridge (pylus) which is a prerequisite for the genetic transfer from one bacteria to another.
Introduction
The demand for pork and poultry products is strongly influenced by the consumers concern for healthy and safe food. The topic of food safety mainly concentrates on Salmonella contamination and is recently joined by the topic of antimicrobial resistance due to the use of antimicrobial growth promoters (AGP) in animal feed. Latest findings on flavophospholipol, registered as AGP for pigs, poultry and several other species, describe a reducing effect on the development of antibiotic resistance and on the frequency of plasmid transfer. 
Methods
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same manner as described above. The other trial was conducted by Riedl et. al (2000) . Three vancomycin A-resistant field strains of Enterococcus faecium were co-cultivated with some Enterococcus faecium strains which were still sensible to vancomycin A. The transfer frequency of vancomycin A resistance encoding plasmids was examined after giving various concentrations of flavophospholipol to the nutrient solutions. For control vancomycin A itself was mixed into the cultivated solution in different concentrations.
Results The first study clearly shows an increase of antibiotic resistance of the isolated E. coli strains to all tested antibiotics in the control and in the avoparcin group. In the Flavomycin TM group the occurrence of antibiotic resistances was unchanged or slightly diminished. The prevalence of VRE in the vancomycin-group increased significantly during the trial as compared to the control and flavophospholipol group. The other experiment resulted in a decrease of the transfer of vancomycin A resistance encoding plasmids in a dose dependent manner in the presence of flavophospholipol. In the presence of vancomycin this effect was not observed.
Conclusions
Flavophospholipol does not induce an antibiotic resistance to antibiotics used for veterinary
or human therapy as it is not related to any antibiotic used for these purposes. 2. Furthermore it is capable of reducing antibiotic resistance to other antibiotics. This effect seems to be yielded by interfering in the biosynthesis of the plasmid bridge (pylus) which is a prerequisite for the genetic transfer from one bacteria to another. 3. These findings confirm previous studies by Dealy and Moeller, which described flavophospholipol's ability to significantly reduce the number of antibiotic-resistant Salmonella in pigs and calves. 
